Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry...
Download
1 / 27

Forum 4 - PowerPoint PPT Presentation


  • 538 Views
  • Updated On :

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research. CEITEC – Central European Institute of Technology Mgr. Tomáš Hruda.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Forum 4 ' - HarrisCezar


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Slide1 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC – Central European Institute of Technology

    • Mgr. Tomáš Hruda


Slide2 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC – Central European Institute of Technology

    • Location: Brno, South Moravian Region

    • Vision: Establish a Centre of Excellence conducting research in the area of Quality of Life and Human Health.

    • Funding: structural funds - Operational program R&D for Innovation 2007-2013, already selected for the Indicative list of projects, app. 320 mil. EUR.

    • Schedule:

      • 2009 – full call for proposals

      • 2010 – project approval (both CZ and European Commission)

      • 2010-2014 – construction and acquisition of equipment


Slide3 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC – Why Brno as a location?

  • 32 % of public R&D spending (without Prague).

  • 3.000 researchers in engineering and life science.

  • Wide range of research facilities.

  • Long history of technology and medical research development and production.

  • 6 public universities with 80.000+ students.

  • Clear & functional regional innovation strategy.


Slide4 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC – strong team of partners

  • Masaryk University

  • Brno University of Technology

  • Mendel University of Agriculture and Forestry

  • University of Veterinary and Pharmaceutical Sciences

  • Institutes of the Academy of Sciences of the Czech Republic:

    • Institute of Biophysics, Institute of Scientific Instruments, Institute of Analytical Chemistry, Institute of Physics of Materials

  • Veterinary Research Institute

    … bundling together best research groups of Southern Moravia accross institutions


Slide5 l.jpg

CEITEC and Collaboration of Academia and Industry for Central European Biotech research

Applied neuroscience and molecular medicine

Cell and molecular biology of model systems

Advanced biomedical modelling and veterinary science

Structural biology and molecular biophysics

Advanced materials

Advanced nano- and micro- technologies

Biomedical technologies

Advanced communication & IT

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC – research programmes

  • blending Life Sciences and Advanced Materials and Technologies


Slide6 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC – Central European Institute of Technology

    • Main principles:

      • Clear focus (Quality of Life and Human Health), vision (scientific excellence) and corresponding managerial structure.

      • Transparent and effective rules for cooperation with the private sector.

      • Openness to excellent scientists (Czech or foreign).

    • Connecting to Europe - ESFRI:to be associated to large scale EU research infrastructures INSTRUCT (structural biology) and PRINS (nanostructures).


Slide7 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC

    • Contacts

      • CEITEC – Central European Institute of Technology Žerotínovo nám. 9

        601 77 Brno

        Czech Republic

      • E-mail:[email protected]

      • Web:www.ceitec.eu

    • Project director

      • Tomáš Hruda,[email protected]


Slide8 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC Cluster Bioinformatics

    • Ing. Stanislav Mrázek


Slide9 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC Cluster Bioinformatics

    • Main Activities

      • Marketing

      • Human Resources

      • Consultancy

    • CEITEC Cluster Bioinformatics associates commercial companies and research institutes both public and private.

    • Main objective of cluster is to foster mutual collaboration in order to increase competitive advantage of the members.

  • Ideas Exchange

  • CEITEC Project

  • Joint Research Projects


Slide10 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC Cluster Bioinformatics

    • Members

      • Bio-Vendor, Laboratory medicine a.s.

      • Camea s.r.o.

      • Eco – Management s.r.o.

      • Enantis s.r.o.

      • Elisabeth Pharmacom s.r.o.

      • Favea s.r.o.

      • FEI Czech Republic s.r.o.

      • South Moravian Center for International Mobility

  • MAC s.r.o.

  • Tescan s.r.o.

  • Textilní zkušební ústav

  • Výzkumný ústav pletařský

  • Masaryk Univerzity

  • Biophysical Institute Academy of Science

  • FTM Communications, s.r.o.


Slide11 l.jpg

CEITEC Cluster Bioinformatics and Collaboration of Academia and Industry for Central European Biotech research

Members

Jihočeská agentura pro podporu inovativního podnikání o.p.s.

South Moravian Regional Development Agency

ENVISAN-GEM a.s.

STROKOM, s.r.o.

NETS.CZ, s.r.o.

HDT s.r.o.

Enzymo Plus s.r.o.

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • GEN - TREND s.r.o.

  • Vidia spol. s r.o.

  • Center of Cardiovascular and transplantation Surgery


Slide12 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CEITEC Cluster Bioinformatics

    • Contacts

      • Address: U Vodárny 2, 616 00, Brno, Czech Republic

      • Mobil: + 420 608 022 220

      • E-mail: [email protected]

      • www.ceitec-cluster.cz


Slide13 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • International Clinical Research Center Brno

  • MUDr. Tomáš Kára, PhD.


Slide14 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • International Clinical Research Center Brno

    • Location: St. Anne’s University Hospital Brno.

    • Mission: Establishing the first international center for applied medical research capable of accelerating research process and knowledge transfer from bench to bedside.

    • Key aspects:Novel concept and logistics of scientific collaboration & strong transatlantic partnership.

    • Strategic U.S. Partner: Mayo Clinic (Rochester, MN, USA)

    • Funding: Approved as strategic project of the Government of the Czech Republic with budget of 80 mil. EUR. Construction expected to be completed in 12/2010.

    • Global position: After CERN and International Space Station, ICRC Brno will be the third international research center sharing identical principles and valueswith CERN and ISS.


Slide15 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • ICRC Brno – Science without Borders

  • Key directions: cardiovascular, neurosciences and oncology R&D


Slide16 l.jpg

UT and Collaboration of Academia and Industry for Central European Biotech research

ISI

CEITEC

TECHNOLOGY

TECHNOPARK BRNO

University Campusbasic research

Animal Res. Centerpreclinical R&D

SYNERGY

  • ICRC Brno- Brno Biotech Partnership

ICRC

Translational research, international collaboration


Slide17 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • International Clinical Research Center Brno

  • Contacts:

    • Address:Fakultní nemocnice u sv. Anny, ICRC, Pekařská 53, 656 91, Brno

    • E-mail: [email protected]

    • Telephone: + 420 543 181 161

    • www.icrcbrno.org


Slide18 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • BIOCEV - Biotech & Biomed Research Center of Academy of Science and Charles University

    • Ing. Peter Šebo, CsC.


Slide19 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • Biotech & Biomed Research Center of Academy of Science and Charles University

    • Location: Central Bohemia Region, Vestec u Prahy

    • Main objective: Regional development and competitiveness through promotion of cutting-edge biotechnology and biomedical R&D in Czech Republic.

    • Selected for the Indicative list of projects of the Operationsl program R&D for Innovation European Regional Development Fund 2007 – 2013.


Slide20 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • Biotech & Biomed Research Centre of Academy of Science and Charles University

    • Budget: 114 mil. € without start-up

    • Main milestones:

      • December 2007 – Consortium agreement

      • February 2008 – BIOCEV registered as a legal entity

      • March 2009 – project submitted to the Ministry of Education of CR

      • October 2010 – construction starts

      • October 2013 – BIOCEV full operation


Slide21 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • Biotech & Biomed Research Center of Academy of Science and Charles University

    • Activities

      • Graduate education

      • International school of advanced studies in biotechnology and biomedcine

      • Basic research

      • Oriented research

      • Cell culture

      • Protection of itellectual property, technology transfer and bussines development

  • Mouse clinic

  • Structural Biology

  • Imaging


Slide22 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • Biotech & Biomed Research Center of Academy of Science and Charles University

    • Project coordinator:

      Ing. Peter Šebo Csc. - [email protected]

    • Project secretary:

      MUDr. Jan Rajnoch – [email protected]


Slide23 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CzechBio,

    Association of Biotechnology companies

    • MUDr. Jan Rajnoch


Slide24 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • CzechBio,

    Association of Biotechnology companies

    • Founded 18th Dcember 2008

    • 25 members

      • 1 university

      • 1 public research institute of the Academy of Science


Slide25 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • Czech Bio,

    Association of Biotechnology companies

    • Biotech cluster activities:

      • Communication

      • Associative activities

      • Lobbying

      • Joint business development

      • Research collaborations

      • Education of human resources

      • Joint presentations abroad

      • Mingling sessions

      • Interaction with government


Slide26 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • Czech Bio,

    Association of Biotechnology companies

    • Founding members:

  • Apronex s.r.o.

  • Ascoprot Biotech s.r.o.

  • BIOFARM, Výzkumný ústav biofarmacie a veterinárních léčiv

  • BioTest s.r.o.

  • BioVendor – Laboratorní medicína a.s.

  • BioVeta a.s.

  • BVT Technologies a.s.

  • CS – Project s.r.o.

  • Enantis s.r.o.

  • Envisan-Gem a.s.

  • EPS s.r.o.

  • Generi Biotech s.r.o.

  • Labina s.r.o.

  • LentiKat‘s a.s.

  • Lonza Biotech s.r.o.

  • Protean s.r.o.

  • Proteix s.r.o.

  • Sevapharma a.s.

  • Top Bio s.r.o.

  • Vidia s.r.o.


Slide27 l.jpg

Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research

  • Czech Bio,

    Association of Biotechnology companies

    • Managers

      • MUDr. Jan Rajnoch [email protected]

      • Ilona Dita [email protected]

    • Seat

      • Nad Safinou II/366, 222 42 Vestec

    • Contact

      • BTÚ, Jan Rajnoch, Vídeňská 1083, 142 20 Praha 4


ad